ROCKWELL MEDICAL, INC. Depreciation
ROCKWELL MEDICAL, INC. (RMTI) reported Depreciation of $400.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. depreciation for the quarter ending 2026-06-30 was $400.00K, a 0.00% change year-over-year.
- ROCKWELL MEDICAL, INC. depreciation for the quarter ending 2026-03-31 was $400.00K, a 0.00% change year-over-year.
- ROCKWELL MEDICAL, INC. depreciation for the quarter ending 2025-12-31 was $400.00K, a 0.00% change year-over-year.
- ROCKWELL MEDICAL, INC. depreciation for the quarter ending 2025-09-30 was $400.00K, a 0.00% change year-over-year.
- ROCKWELL MEDICAL, INC. depreciation for fiscal 2025 was $1.60M, a 0.00% change from fiscal 2024.
- ROCKWELL MEDICAL, INC. depreciation for fiscal 2024 was $1.60M, a 33.33% increase from fiscal 2023.
- ROCKWELL MEDICAL, INC. depreciation for fiscal 2023 was $1.20M, a 100.00% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. depreciation for fiscal 2022 was $600.00K, a 10.18% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $400.00K 10-Q · filed 2026-08-13 | $700.00K 10-Q · filed 2026-08-13 | $1.20M derived: sum of 3 quarters · filed 2026-08-13 | $1.60M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $400.00K 10-Q · filed 2026-05-07 | $800.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.20M derived: sum of 3 quarters · filed 2026-05-07 | $1.60M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $800.00K derived: sum of 2 quarters · filed 2026-03-26 | $1.20M derived: sum of 3 quarters · filed 2026-08-13 | $1.60M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-12 | $800.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.20M 10-Q · filed 2025-11-12 | $1.60M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $400.00K 10-Q · filed 2026-08-13 | $800.00K 10-Q · filed 2026-08-13 | $1.20M derived: sum of 3 quarters · filed 2026-08-13 | $1.60M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $400.00K 10-Q · filed 2026-05-07 | $800.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.20M derived: sum of 3 quarters · filed 2026-05-07 | $1.60M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $800.00K derived: sum of 2 quarters · filed 2026-03-26 | $1.20M derived: sum of 3 quarters · filed 2026-03-26 | $1.60M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $400.00K 10-Q · filed 2025-11-12 | $800.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.20M 10-Q · filed 2025-11-12 | $1.60M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $400.00K 10-Q · filed 2025-08-14 | $800.00K 10-Q · filed 2025-08-14 | $1.20M derived: sum of 3 quarters · filed 2025-08-14 | $1.60M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $400.00K 10-Q · filed 2024-05-14 | $800.00K derived: sum of 2 quarters · filed 2025-03-20 | $1.20M derived: sum of 3 quarters · filed 2025-03-20 | $1.40M derived: sum of 4 quarters · filed 2025-03-20 | ||||
| 2023-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $800.00K derived: sum of 2 quarters · filed 2025-03-20 | $1.00M derived: sum of 3 quarters · filed 2025-03-20 | $1.20M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $400.00K 10-Q · filed 2024-11-12 | $600.00K derived: sum of 2 quarters · filed 2024-11-12 | $800.00K 10-Q · filed 2024-11-12 | $1.00M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $200.00K 10-Q · filed 2024-08-08 | $300.00K 10-Q · filed 2024-08-08 | $600.00K derived: sum of 3 quarters · filed 2024-08-08 | $700.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-14 | $400.00K derived: sum of 2 quarters · filed 2024-05-14 | $500.00K derived: sum of 3 quarters · filed 2024-05-14 | $600.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $300.00K derived: sum of 2 quarters · filed 2024-03-21 | $400.00K derived: sum of 3 quarters · filed 2024-03-21 | $600.00K 10-K · filed 2024-03-21 | $576.00K 10-K · filed 2023-03-30 | |||
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-14 | $200.00K derived: sum of 2 quarters · filed 2023-11-14 | $400.00K 10-Q · filed 2023-11-14 | $468.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-14 | $300.00K 10-Q · filed 2023-08-14 | $368.00K derived: sum of 3 quarters · filed 2023-08-14 | $468.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-15 | $268.00K derived: sum of 2 quarters · filed 2023-05-15 | $368.00K derived: sum of 3 quarters · filed 2023-05-15 | $568.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $268.00K derived: sum of 2 quarters · filed 2023-03-30 | $468.00K derived: sum of 3 quarters · filed 2023-03-30 | $668.00K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-14 | $300.00K derived: sum of 2 quarters · filed 2022-11-14 | $500.00K 10-Q · filed 2022-11-14 | $734.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $200.00K 10-Q · filed 2022-08-15 | $400.00K 10-Q · filed 2022-08-15 | $200.00K 10-Q · filed 2021-08-16 | $634.00K derived: sum of 3 quarters · filed 2022-08-15 | $834.00K derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-16 | $434.00K derived: sum of 2 quarters · filed 2022-05-16 | $634.00K derived: sum of 3 quarters · filed 2022-05-16 | $1.03M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $434.00K derived: sum of 2 quarters · filed 2022-04-08 | $834.00K derived: sum of 3 quarters · filed 2022-04-08 | $834.00K 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-15 | $600.00K derived: sum of 2 quarters · filed 2021-11-15 | $600.00K 10-Q · filed 2021-11-15 | $988.00K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $400.00K 10-Q · filed 2021-08-16 | $200.00K 10-Q · filed 2020-08-10 | $400.00K 10-Q · filed 2021-08-16 | $788.00K derived: sum of 3 quarters · filed 2021-08-16 | $988.00K derived: sum of 4 quarters · filed 2021-08-16 | |||
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-17 | $388.00K derived: sum of 2 quarters · filed 2021-05-17 | $588.00K derived: sum of 3 quarters · filed 2021-05-17 | $788.00K derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $388.00K derived: sum of 2 quarters · filed 2021-03-31 | $588.00K derived: sum of 3 quarters · filed 2021-03-31 | $788.00K 10-K · filed 2021-03-31 | $787.82K 10-K · filed 2020-03-17 | |||
| 2019-09-30 | $200.00K 10-Q · filed 2020-11-09 | $400.00K derived: sum of 2 quarters · filed 2020-11-09 | $600.00K 10-Q · filed 2020-11-09 | $580.00K 10-Q · filed 2019-11-12 | $779.79K derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | $200.00K 10-Q · filed 2020-08-10 | $400.00K 10-Q · filed 2020-08-10 | $579.79K derived: sum of 3 quarters · filed 2020-08-10 | $779.79K derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $200.00K 10-Q · filed 2020-05-11 | $379.79K derived: sum of 2 quarters · filed 2020-05-11 | $579.79K derived: sum of 3 quarters · filed 2020-05-11 | $779.79K derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $179.79K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $379.79K derived: sum of 2 quarters · filed 2020-03-17 | $579.79K derived: sum of 3 quarters · filed 2020-03-17 | $649.79K 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | $200.00K 10-Q · filed 2019-11-12 | $185.58K 10-Q · filed 2018-11-09 | $400.00K derived: sum of 2 quarters · filed 2019-11-12 | $470.00K 10-Q · filed 2019-11-12 | $466.73K 10-Q · filed 2018-11-09 | $629.17K derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $200.00K 10-Q · filed 2019-08-09 | $152.16K 10-Q · filed 2018-08-14 | $300.00K 10-Q · filed 2019-08-09 | $281.15K 10-Q · filed 2018-08-14 | $429.17K derived: sum of 3 quarters · filed 2019-08-09 | $555.01K derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | $100.00K 10-Q · filed 2019-05-10 | $229.17K derived: sum of 2 quarters · filed 2019-05-10 | $355.01K derived: sum of 3 quarters · filed 2019-05-10 | $483.79K derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $129.17K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $255.01K derived: sum of 2 quarters · filed 2019-03-18 | $383.79K derived: sum of 3 quarters · filed 2019-03-18 | $514.01K 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | $125.84K 10-Q · filed 2018-11-09 | $254.62K derived: sum of 2 quarters · filed 2018-11-09 | $384.83K 10-Q · filed 2018-11-09 | |||||
| 2017-06-30 | $128.78K 10-Q · filed 2018-08-14 | $258.91K 10-Q · filed 2018-08-14 | ||||||
| 2016-12-31 | $601.09K 10-K · filed 2018-03-15 | |||||||
| 2015-12-31 | $655.26K 10-K · filed 2018-03-15 | |||||||
| 2014-12-31 | $829.29K 10-K · filed 2017-03-15 | |||||||
| 2013-12-31 | $840.38K 10-K · filed 2016-02-29 | |||||||
| 2012-12-31 | $920.37K 10-K · filed 2015-03-03 | |||||||
| 2011-12-31 | $1.14M 10-K · filed 2014-03-07 | |||||||
| 2010-12-31 | $1.34M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |